Coffee, cirrhosis, and transaminase enzymes

Archives of Internal Medicine

Volumn 166, Issue 11, 2006, Pages 1190-1195

  Klatsky, Arthur L ^a   Morton, Cynthia ^b   Udaltsova, Natalia ^a   Friedman, Gary D ^a  

^a DIVISION OF RESEARCH   (United States)

^b KAISER PERMANENTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE;

ADULT; AGED; ALCOHOLISM; AMINOTRANSFERASE BLOOD LEVEL; COFFEE; CONTROLLED STUDY; DRINKING BEHAVIOR; HEALTH INSURANCE; HUMAN; LIVER CIRRHOSIS; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MEDICAL EXAMINATION; MEDICAL RECORD; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; RACE DIFFERENCE; REVIEW;

ALANINE TRANSAMINASE; ASPARTATE AMINOTRANSFERASES; COFFEE; COHORT STUDIES; CROSS-SECTIONAL STUDIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; LIVER CIRRHOSIS; MALE; MIDDLE AGED;

EID: 33745038932     PISSN: 00039926     EISSN: 15383679     Source Type: Journal    
DOI: 10.1001/archinte.166.11.1190     Document Type: Review

References (34)

1. Pequignot G, Tuyns AJ, Berta JL. Ascitic cirrhosis in relation to alcohol consumption. Int J Epidemiol. 1978;7:113-120.
2. Saunders JB, Walters JR, Davies AP, Paton A. A 20-year prospective study of cirrhosis. Br Med J (Clin Res Ed). 1981;282:263-266.
3. Smart RG, Mann RE. Alcohol and the epidemiology of liver cirrhosis. Alcohol Health Res World. 1992;16:217-222.
4. Corrao G, Arico S. Alcohol and liver cirrhosis: old questions and weakly explored opportunities. Addiction. 2000;95:1267-1270.
5. Corrao G, Zambon A, Bagnardi V, D'Amicis A, Klatsky A; Collaborative SIDECIR Group. Coffee, caffeine, and the risk of liver cirrhosis. Ann Epidemiol. 2001;11:458-465.
6. Lelbach WK. Epidemiology of alcoholic liver disease. Prog Liver Dis. 1976;5:494-515.
7. Mezey E. Dietary fat and alcoholic liver disease. Hepatology. 1998;28:901-905.
8. Corrao G, Bagnardi V, Zambon A, Arico S. Exploring the dose-response relationship between alcohol consumption and the risk of several alcohol-related conditions: a meta-analysis. Addiction. 1999;94:1551-1573.
9. Lieber CS. Alcohol: its metabolism and interaction with nutrients. Annu Rev Nutr. 2000;20:395-430.
10. Grant BF, Dufour MC, Harford TC. Epidemiology of alcoholic liver disease. Semin Liver Dis. 1988;8:12-25.
11. Stinson FS, Grant BF, Dufour MC. The critical dimension of ethnicity in liver cirrhosis mortality statistics. Alcohol Clin Exp Res. 2001;25:1181-1187.
12. Bellentani S, Saccoccio G, Masutti F, et al. Risk factors for alcoholic liver disease. Addict Biol. 2000;5:261-268.
13. Klatsky AL, Armstrong MA. Alcohol, smoking, coffee, and cirrhosis. Am J Epidemiol. 1992;136:1248-1257.
14. Corrao G, Lepore AR, Torchio P, et al; Provincial Group for the Study of Chronic Liver Disease. The effect of drinking coffee and smoking cigarettes on the risk of cirrhosis associated with alcohol consumption: a case-control study. Eur J Epidemiol. 1994;10:657-664.
15. Gallus S, Tavani A, Negri E, La Vecchia C. Does coffee protect against liver cirrhosis? Ann Epidemiol. 2002;12:202-205.
16. Tverdal A, Skurtveit S. Coffee intake and mortality from liver cirrhosis. Ann Epidemiol. 2003;13:419-423.
17. Gallus S, Bertuzzi M, Tavani A, et al. Does coffee protect against hepatocellular carcinoma? Br J Cancer. 2002;87:956-959.
18. Inoue M, Yoshimi I, Sobue T, Tsugane S; JPHC Group. Influence of coffee drinking on subsequent risk of hepatocellular carcinoma: a prospective study in Japan. J Natl Cancer Inst. 2005;97:293-300.
19. Shimazu T, Tsubono Y, Kuriyama S, et al. Coffee consumption and the risk of primary liver cancer: pooled analysis of two prospective studies in Japan. Int J Cancer. 2005;10:150-154.
20. Casiglia E, Spolaore P, Ginocchio G, Ambrosio GB. Unexpected effects of coffee consumption on liver enzymes. Eur J Epidemiol. 1993;9:293-297.
21. Sharp DS, Everhart JE, Benowitz NL. Coffee, alcohol, and the liver. Ann Epidemiol. 1999;9:391-393.
22. Ruhl CE, Everhart JE. Coffee and caffeine consumption reduce the risk of elevated serum alanine aminotransferase activity in the United States. Gastroenterology. 2005;128:28-32.
23. Collen MF, Davis LF. The multitest laboratory in health care. J Occup Med. 1969;11:355-360.
24. Krieger N. Overcoming the absence of socioeconomic data in medical records: validation and application of a census-based methodology. Am J Public Health. 1992;82:703-710.
25. World Health Organization. International Classification of Diseases, Ninth Revision (ICD-9) . Geneva, Switzerland: World Health Organization; 1977.
26. Schreiber GB, Robins M, Maffeo CE, Masters MN, Bond AP, Morganstein D. Confounders contributing to the reported associations of coffee or caffeine with disease. Prev Med. 1988;17:295-309.
27. Amit Z, Weiss S, Smith BR, Markevitch S. Use of caffeine-based products and tobacco in relation to the consumption of alcohol: an examination of putative relationships in a group of alcoholics in Israel. Eur Addict Res. 2004;10:22-28.
28. Bisceglie AM, Rustgi V, Hoofnagle JH, Dusheiko GM, Lotze MT. Hepatocellular carcinoma. Ann Intern Med. 1988;108:390-401.
29. Kubo Shlonsky A, Klatsky AL, Armstrong MA. Traits of persons who drink decaffeinated coffee. Ann Epidemiol. 2003;13:273-279.
30. Ruhl CE, Everhart JE. Coffee and tea consumption are associated with a lower incidence of chronic liver disease in the United States. Gastroenterology. 2005;129:1928-1936.
31. National Coffee Association. National Coffee Drinking Trends. New York, NY: National Coffee Association of USA; 2000.
32. Spiller G, ed. The Chemical Components of Coffee. New York, NY: Alan R Liss; 1984.
33. Joeres R, Klinker H, Heusler H, Epping J, Zilly W, Richter E. Influence of smoking on caffeine elimination in healthy volunteers and in patients with alcoholic liver cirrhosis. Hepatology. 1988;8:575-579.
34. Midanik LT, Klatsky AL, Armstrong MA. Changes in drinking behavior: demographic, psychosocial, and biomedical factors. Int J Addict. 1990;25:599-619.